| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |